Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

5.51
Delayed Data
As of Dec 02
 +0.335 / +6.47%
Today’s Change
1.63
Today|||52-Week Range
10.98
-46.61%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Revenue and IncomeNet Revenues4.6M4.8M4.8M7.8M
 
 
 
 
 
Cost of Goods Sold6.5K30.0K27.0K55.5K
 
 
 
 
 
Depreciation And Amortization43.0K47.0K89.0K175.0K
 
 
 
 
 
 
Operating ExpensesGross Income4.6M4.7M4.7M7.5M
 
 
 
 
 
General Expenses21.7M23.8M16.8M16.8M
 
 
 
 
 
Research And Development19.0M20.6M14.2M14.1M
 
 
 
 
 
Total Operating Expenses21.8M23.9M16.9M17.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-17.2M-19.0M-12.1M-9.2M
 
 
 
 
 
Extraordinary Credit229.0K0.000.000.00
 
 
Extraordinary Charge0.00-2.8M-2.9M-931.0K
 
 
 
 
Interest Expense On Debt1.3M1.5M1.4M1.5M
 
 
 
 
 
Other Expenses0.000.000.001.0K
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-18.1M-22.8M-16.3M-11.5M
 
 
 
 
 
Net Income-18.1M-22.8M-16.3M-11.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS73.3M73.6M73.7M73.7M
 
 
 
 
 
Shares To Calculate EPS Diluted73.3M73.6M73.7M73.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.25-$0.31-$0.22-$0.16
 
 
 
 
 
EPS Diluted-$0.25-$0.31-$0.22-$0.16